{"transactions":[{"id":1483262,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":90045,"kind":"person","name":"Ebeling Thomas","position":1,"cik":"0001297759","reported_name":"Ebeling Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T18:00:03.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":false,"shares":18450,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13,"exercise_date":"2024-06-08","expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":18450},"source":{"system":"sec-edgar","filing":"0000950170-24-072095","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1297759/000095017024072095/ownership.xml","form_type":"4"}},{"id":1483261,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":90045,"kind":"person","name":"Ebeling Thomas","position":1,"cik":"0001297759","reported_name":"Ebeling Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T18:00:03.000Z","date":"2024-06-10","kind":"exercise","planned":false,"acquired":true,"shares":18450,"price":13,"value":239850.0,"ownership":{"direct":true},"balance_after":186653,"source":{"system":"sec-edgar","filing":"0000950170-24-072095","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297759/000095017024072095/ownership.xml","form_type":"4"}},{"id":1503489,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":90045,"kind":"person","name":"Ebeling Thomas","position":1,"cik":"0001297759","reported_name":"Ebeling Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-23T16:11:26.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":false,"shares":16475,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":12.73,"exercise_date":"2023-06-08","expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":16475},"source":{"system":"sec-edgar","filing":"0000950170-24-063948","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1297759/000095017024063948/ownership.xml","form_type":"4"}},{"id":1503488,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":90045,"kind":"person","name":"Ebeling Thomas","position":1,"cik":"0001297759","reported_name":"Ebeling Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-23T16:11:26.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":false,"shares":84224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vested on August 16, 2018, and the remaining shares vested in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":4.3,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":84224},"source":{"system":"sec-edgar","filing":"0000950170-24-063948","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1297759/000095017024063948/ownership.xml","form_type":"4"}},{"id":1503487,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":90045,"kind":"person","name":"Ebeling Thomas","position":1,"cik":"0001297759","reported_name":"Ebeling Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T16:11:26.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":16475,"price":12.73,"value":209726.75,"ownership":{"direct":true},"balance_after":168203,"source":{"system":"sec-edgar","filing":"0000950170-24-063948","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1297759/000095017024063948/ownership.xml","form_type":"4"}},{"id":1503486,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":90045,"kind":"person","name":"Ebeling Thomas","position":1,"cik":"0001297759","reported_name":"Ebeling Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T16:11:26.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":84224,"price":4.3,"value":362163.2,"ownership":{"direct":true},"balance_after":151728,"source":{"system":"sec-edgar","filing":"0000950170-24-063948","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297759/000095017024063948/ownership.xml","form_type":"4"}},{"id":1858585,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":90045,"kind":"person","name":"Ebeling Thomas","position":1,"cik":"0001297759","reported_name":"Ebeling Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T17:58:25.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":18450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 18,450 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 8, 2024 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date."}],"balance_after":18450,"derivative":{"exercise_price":13,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":18450},"source":{"system":"sec-edgar","filing":"0000950170-23-027540","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297759/000095017023027540/ownership.xml","form_type":"4"}},{"id":2222938,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":90045,"kind":"person","name":"Ebeling Thomas","position":1,"cik":"0001297759","reported_name":"Ebeling Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-23T18:23:56.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":16475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 16,475 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 22, 2023 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date."}],"balance_after":16475,"derivative":{"exercise_price":12.73,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":16475},"source":{"system":"sec-edgar","filing":"0000899243-22-023773","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297759/000089924322023773/doc4.xml","form_type":"4"}},{"id":2317602,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":90045,"kind":"person","name":"Ebeling Thomas","position":1,"cik":"0001297759","reported_name":"Ebeling Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-25T19:35:42.000Z","date":"2021-09-16","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 7,800 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 25, 2022 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date."}],"balance_after":7800,"derivative":{"exercise_price":28.8,"expiration_date":"2031-09-15","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0000899243-22-012380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1297759/000089924322012380/doc4.xml","form_type":"4"}}]}